Literature DB >> 21449029

Use of three-dimensional spheroids of hepatocyte-derived reporter cells to study the effects of intracellular fat accumulation and subsequent cytokine exposure.

Amol V Janorkar1, Lacey M Harris, Beau S Murphey, Brittany L Sowell.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a family of liver diseases associated with obesity. Initial stage of NAFLD is characterized by a fatty liver, referred to as steatosis, which progresses in some individuals to non-alcoholic steatohepatitis (NASH) and liver failure. In order to study and treat the many liver diseases such as NAFLD, an improved in vitro cellular model is needed. Several studies in the past have attempted to elucidate these mechanisms using primary hepatocytes or relevant hepatoma cell lines in two-dimensional (2D) monolayer in vitro cultures. These 2D planar culture systems, unfortunately, do not represent the complex architecture of hepatic tissue in vivo. Therefore, we have engineered an elastin-like polypeptide (ELP)-polyethyleneimine (PEI) copolymer and shown that ELP-PEI coated surfaces influenced H35 rat hepatoma cell morphology to create 3D spheroids. Our reporter cell model recapitulates many cellular features of the human disease, including fatty acid uptake, intracellular triglyceride accumulation, decreased proliferation, decreased liver-specific function, and increased reactive oxygen species accumulation. Finally, to demonstrate the utility of the reporter cells for studying transcriptional regulation, we compared the transcriptional dynamics of nuclear factor κB (NFκB) in response to its classical inducer (tumor necrosis factor-α, TNF-α) under lean and fatty conditions in both 2D and 3D culture configurations. We found that, in 3D spheroids, linoleic acid treatment activated NFκB at earlier time points during the development of steatosis, but suppressed the TNF-mediated NFκB activation at later time points. These studies therefore provide a good starting point to evaluate such relationships observed during NAFLD in a 3D in vitro cell culture.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21449029     DOI: 10.1002/bit.23025

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  10 in total

1.  Characterizing the dielectric properties of human mesenchymal stem cells and the effects of charged elastin-like polypeptide copolymer treatment.

Authors:  T N G Adams; P A Turner; A V Janorkar; F Zhao; A R Minerick
Journal:  Biomicrofluidics       Date:  2014-09-16       Impact factor: 2.800

Review 2.  Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research.

Authors:  Joost Willebrords; Isabel Veloso Alves Pereira; Michaël Maes; Sara Crespo Yanguas; Isabelle Colle; Bert Van Den Bossche; Tereza Cristina Da Silva; Cláudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Alves; Bruno Cogliati; Mathieu Vinken
Journal:  Prog Lipid Res       Date:  2015-06-11       Impact factor: 16.195

Review 3.  Stem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver Injury.

Authors:  Winfried Krueger; Urs A Boelsterli; Theodore P Rasmussen
Journal:  J Clin Transl Hepatol       Date:  2014-09-15

4.  Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease.

Authors:  Tomasz Kostrzewski; Terri Cornforth; Sophie A Snow; Larissa Ouro-Gnao; Cliff Rowe; Emma M Large; David J Hughes
Journal:  World J Gastroenterol       Date:  2017-01-14       Impact factor: 5.742

5.  An in vitro model using spheroids-laden nanofibrous structures for attaining high degree of myoblast alignment and differentiation.

Authors:  Miji Yeo; SooJung Chae; GeunHyung Kim
Journal:  Theranostics       Date:  2021-01-16       Impact factor: 11.556

6.  Human Nonalcoholic Steatohepatitis on a Chip.

Authors:  May S Freag; Bumseok Namgung; Maria E Reyna Fernandez; Ermanno Gherardi; Shiladitya Sengupta; Hae Lin Jang
Journal:  Hepatol Commun       Date:  2020-11-29

7.  The transcriptional landscape of a hepatoma cell line grown on scaffolds of extracellular matrix proteins.

Authors:  Souvik Ghosh; Anastasiya Börsch; Shreemoyee Ghosh; Mihaela Zavolan
Journal:  BMC Genomics       Date:  2021-04-06       Impact factor: 3.969

Review 8.  In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD).

Authors:  Giridhar Kanuri; Ina Bergheim
Journal:  Int J Mol Sci       Date:  2013-06-05       Impact factor: 5.923

9.  Application of elastin-mimetic recombinant proteins in chemotherapeutics delivery, cellular engineering, and regenerative medicine.

Authors:  Won Bae Jeon
Journal:  Bioengineered       Date:  2013-03-08       Impact factor: 3.269

10.  A Microphysiological System for Studying Nonalcoholic Steatohepatitis.

Authors:  Tomasz Kostrzewski; Paloma Maraver; Larissa Ouro-Gnao; Ana Levi; Sophie Snow; Alina Miedzik; Krista Rombouts; David Hughes
Journal:  Hepatol Commun       Date:  2019-11-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.